SILENCE THERAP. SP.ADR/1 (XRP2) — Free Cash Flow Generation Index
SILENCE THERAP. SP.ADR/1 (XRP2) has a Free Cash Flow Generation Index of 0.80x as of December 2021. Free cash flow of €7.39 Million represents 1% of operating cash flow (€9.19 Million). Explore XRP2 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
SILENCE THERAP. SP.ADR/1 Free Cash Flow Generation Index (2021–2021)
Historical FCF Generation Index trend for SILENCE THERAP. SP.ADR/1 across 1 annual periods. For the full cash flow conversion analysis, see SILENCE THERAP. SP.ADR/1 cash conversion from operations.
Annual Free Cash Flow Generation for SILENCE THERAP. SP.ADR/1 (2021–2021)
Year-by-year Free Cash Flow Generation Index for SILENCE THERAP. SP.ADR/1. Check SILENCE THERAP. SP.ADR/1 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.80x | €7.39 Million | €9.19 Million | €1.80 Million | — |